Measurement of Urinary Metabolites of Xenobiotics as a Non-Invasive Technique in Toxicology
- 1 January 1982
- book chapter
- Published by Springer Nature
- Vol. 5, 162-178
- https://doi.org/10.1007/978-3-642-68511-8_30
Abstract
To obtain pertinent information on the biotransformation of a compound in the body. By identifying metabolites it is often possible to assess which metabolic pathways at the enzymic level are followed and whether, for example, reactive intermediates are formed. Also quantitative and kinetic information on the disposition of a xenobiotic can be obtained. To use in exposure tests (biological monitoring). The metabolites may be specific or nonspecific for the compound to which exposure takes place. To use as a measure for the activity of metabolic pathways in order to assess interindividual differences in biotransformation, or to assess changes in such pathways by exposure to or ingestion of xenobiotics. In particular in the identification of genetically determined polymorphism of metabolism in man, urinary metabolites have proved to be a very useful tool. Large interindividual differences in the rate of biotransformation of xenobiotics exist and this has important biological (toxicological) implications. The possible value of measuring the urinary metabolite profile of the model compound antipyrine, as a tool in the assessment of the activity of different xenobiotic oxidizing enzymes, is discussed.Keywords
This publication has 33 references indexed in Scilit:
- Metabolic activation and inactivation of chemical mutagens and carcinogensTrends in Pharmacological Sciences, 1981
- Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strainsJournal of Pharmacy and Pharmacology, 1981
- Some observations on the oxidation phenotype status of Nigerian patients presenting with cancerCancer Letters, 1981
- Influence of the Genetically Controlled Deficiency in Debrisoquine Hydroxylation on Antipyrine Metabolite FormationPharmacology, 1981
- Variability in Human Drug MetabolismPublished by Springer Nature ,1980
- Polymorphisms of Oxidation at Carbon Centers of Drugs and Their Clinical SignificanceDrug Metabolism Reviews, 1979
- Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene TreatmentXenobiotica, 1979
- Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in ManPharmacology, 1979
- Individual Differences in the Disposition of Drugs Metabolised in the BodyClinical Pharmacokinetics, 1978
- Biological criteria for selected industrial toxic chemicals: a review.Scandinavian Journal of Work, Environment & Health, 1975